Total submissions: 22
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000075384 | SCV000106379 | no known pathogenicity | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | Multifactorial likelihood analysis posterior probability <0.001 |
Ambry Genetics | RCV000132375 | SCV000187465 | benign | Hereditary cancer-predisposing syndrome | 2014-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000174993 | SCV000226409 | likely benign | not specified | 2014-09-24 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000132375 | SCV000537392 | benign | Hereditary cancer-predisposing syndrome | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000174993 | SCV000539634 | benign | not specified | 2020-08-10 | criteria provided, single submitter | clinical testing | The p.Lys618Thr variant in MLH1 is classified as benign because it has been identified in 0.57% (735/129116, 2 homozygotes) chromosomes by gnomAD (http://gnomad.broadinstitute.org) and is a common haplotype with c.1852A>G. ACMG/AMP Criteria applied: BA1. |
Genetic Services Laboratory, |
RCV000174993 | SCV000595804 | likely benign | not specified | 2017-04-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001080445 | SCV000751221 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000615824 | SCV001136426 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000615824 | SCV001305811 | uncertain significance | Colorectal cancer, hereditary nonpolyposis, type 2 | 2019-06-10 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000174993 | SCV001470327 | benign | not specified | 2019-11-12 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000114853 | SCV001748066 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | MLH1: PP3, BS2 |
Sema4, |
RCV000132375 | SCV002528688 | benign | Hereditary cancer-predisposing syndrome | 2020-05-10 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000174993 | SCV002550417 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002498362 | SCV002809640 | likely benign | Mismatch repair cancer syndrome 1; Muir-Torré syndrome; Colorectal cancer, hereditary nonpolyposis, type 2 | 2022-04-21 | criteria provided, single submitter | clinical testing | |
Institute for Biomarker Research, |
RCV000132375 | SCV002819230 | benign | Hereditary cancer-predisposing syndrome | 2022-11-22 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149735 | SCV003838214 | likely benign | Breast and/or ovarian cancer | 2023-06-22 | criteria provided, single submitter | clinical testing | |
Harris Lab, |
RCV000114853 | SCV000148748 | not provided | not provided | no assertion provided | not provided | ||
Pathway Genomics | RCV000144601 | SCV000189928 | likely benign | Lynch syndrome 1 | 2014-07-24 | no assertion criteria provided | clinical testing | |
CSER _CC_NCGL, |
RCV000148619 | SCV000190334 | uncertain significance | Colorectal cancer, non-polyposis | 2014-06-01 | no assertion criteria provided | research | |
Mayo Clinic Laboratories, |
RCV000174993 | SCV000257071 | uncertain significance | not specified | no assertion criteria provided | research | ||
Department of Pathology and Laboratory Medicine, |
RCV000114853 | SCV000592425 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000174993 | SCV001970435 | benign | not specified | no assertion criteria provided | clinical testing |